Cost–opportunity analysis in clinical oncology: from the ‘wild far-west’ to a correct integration of the disciplines, avoiding the ‘war of the worlds’-Reference-Cited by-同舟云学术

Cost–opportunity analysis in clinical oncology: from the ‘wild far-west’ to a correct integration of the disciplines, avoiding the ‘war of the worlds’

Published:2006-05 Issue:5 Volume:17 Page:876-877
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Tassinari D.,Poggi B.,Fantini M.,Tamburini E.,Nicoletti S.,Sartori S.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/17/5/876/404545/mdj086.pdf

Reference9 articles.

1. Treatment of advanced breast cancer: the good, the bad and the ugly;Colleoni;Ann Oncol,2005

2. Cyclophosphamide–methotrexate ‘metronomic’ chemotherapy for the palliative treatment of metastatic cancer. A comparative pharmacoeconomic evaluation;Bocci;Ann Oncol,2005

3. The economics of cancer care in the UK;Bosanquet;Lancet Oncol,2004

4. Cancer economics: on variations in the costs of treating cancer;Chirikos;Cancer Control,2002

5. Special Article ASCO. Outcomes of cancer treatment for technology assessment and cancer treatment guidelines;J Clin Oncol,1996

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Emerging Low-dose Therapy for Advanced Cancers;Dose-Response;2009-03-24

2. Reply to the Letter to the Editor on ‘Cost-opportunity analysis in clinical oncology: from the “wild far-west” to a correct integration of the disciplines, avoiding the “war of the worlds”’, by D. Tassinari et al. (Ann Oncol 2006; 17: 876);Annals of Oncology;2006-05

3. Reply to the Letter to the Editor on ‘Cost–opportunity analysis in clinical oncology: from the “wild far-west” to a correct integration of the disciplines, avoiding the “war of the worlds”’, by D. Tassinari et al. (Ann Oncol 2006; 17: 877);Annals of Oncology;2006-05